A Racial Disparity in Schizophrenia Diagnoses in Nursing Homesnews2021-10-15T15:48:02+00:00October 15th, 2021|The New York Times|
F.D.A. Panel Recommends Moderna Booster for Certain Groupsnews2021-10-15T02:10:00+00:00October 15th, 2021|The New York Times|
F.D.A. Panel Greenlights Moderna Boosters for High-Risk Individualsnews2021-10-14T20:51:21+00:00October 14th, 2021|The New York Times|
Where Things Stand on Boosters for Three Vaccines in the U.S.news2021-10-14T19:36:30+00:00October 14th, 2021|The New York Times|
Merck Asks F.D.A. for Emergency Approval of Covid Pillnews2021-10-12T04:25:38+00:00October 12th, 2021|The New York Times|
Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poornews2021-10-09T15:06:57+00:00October 9th, 2021|The New York Times|
Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11news2021-10-08T00:24:12+00:00October 8th, 2021|The New York Times|
Asia-Pacific Countries Rush to Buy Merck Covid Pillnews2021-10-07T12:59:12+00:00October 7th, 2021|The New York Times|
‘Pharma Bro’ Review: Behind the Smirknews2021-10-05T11:00:05+00:00October 5th, 2021|The New York Times|